Shares of Dr. Martens plc (LON:DOCS - Get Free Report) traded up 14.3% during trading on Thursday . The stock traded as high as GBX 71 ($0.96) and last traded at GBX 68.55 ($0.93). 4,561,156 shares were traded during mid-day trading, an increase of 106% from the average session volume of 2,218,223 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analyst Ratings Changes
Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Check Out Our Latest Stock Analysis on DOCS
Dr. Martens Stock Performance
The company has a market cap of £795.54 million, a price-to-earnings ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The stock's fifty day simple moving average is GBX 55.34 and its two-hundred day simple moving average is GBX 62.91. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.
Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities research analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The company also recently declared a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's dividend payout ratio (DPR) is 42.53%.
Insider Buying and Selling
In related news, insider Giles Wilson bought 32,640 shares of the company's stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,857.07). Insiders have bought 33,206 shares of company stock valued at $1,792,771 in the last quarter. Company insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Further Reading
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
